Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Circ Genom Precis Med. 2022 Sep 22;15(5):e003675. doi: 10.1161/CIRCGEN.121.003675

Table 2.

Phenotypes in Carriers of Pathogenic/Likely Pathogenic Variants Associated with Arrhythmogenic Right Ventricular Cardiomyopathy

Carriers (N=18) Noncarriers (N=90) P value
Demographics
 Age, years 69.4 ± 5.7 69.4 ± 5.6 NA
 Female 10 (56%) 50 (56%)
 Genetic ancestry
  European 9 (50%) 45 (50%)
  African 9 (50%) 45 (50%)
Imaging
 Individuals with TTE or CMR 16 (89%) 76 (84%) 1
  TF major imaging criteria 0 0 NA
  TF minor imaging criteria 0 0 NA
Electrocardiogram
 Individuals with electrocardiogram 15 (83%) 84 (93%) 0.2
  TF major electrocardiogram criteria 3 (20%) 3 (4%) 0.04
  TF minor electrocardiogram criteria 6 (40%) 24 (29%) 0.4
Arrhythmias
 Individuals with Holter monitor 4 (22%) 11 (12%) 0.3
  >500 PVCs in 24 hours 2 (50%) 3 (27%) 0.6
 TF major NSVT/VT criteria 0 0 NA
 TF minor NSVT/VT criteria 7 (39%) 16 (18%) 0.06
Pathology
 Individuals with right ventricular tissue sample 2 (11%) 6 (7%) 0.6
  TF major pathology criteria 1 (50%) 0 0.3
  TF minor pathology criteria 0 0 NA
Family history
 TF major criteria (excluding G+) 0 0 NA
 TF minor criteria 1 (6%) 0 0.2
TF diagnostic categories
 None 0 82 (91%) 2×10 −16 *
 Possible 7 (39%) 8 (9%)
 Borderline 5 (28%) 0
 Definite 6 (33%) 0
Other findings
 Any right ventricular dysfunction 4 (25%) 9 (10%) 0.2
 Nonischemic cardiomyopathy 4 (22%) 11 (12%) 0.3
 Syncope 3 (17%) 10 (11%) 0.5
 Atrial fibrillation/flutter 8 (44%) 29 (32%) 0.4
 Implantable cardioverter-defibrillator 4 (22%) 12 (13%) 0.5
 Obstructive coronary artery disease 8 (44%) 57 (63%) 0.2

Continuous measures are described as mean ± standard deviation. Categorical variables are described as N (%); p values are calculated using Fisher’s exact test for dichotomous variables and Wilcoxon rank-sum test for ordinal variables (indicated by *). P values in bold indicate p <0.05. CMR, cardiac magnetic resonance imaging; G+, genotype positivity; NA, not applicable; NSVT, nonsustained ventricular tachycardia; PVC, premature ventricular contraction; TF, 2010 Task Force; TTE, transthoracic echocardiogram; VT, ventricular tachycardia.